A single sequence change destabilizes the influenza virus neuraminidase tetramer

Virology

Volumn 236, Issue 1, 1997, Pages 66-75

  Colacino, Joseph M ^a   Chirgadze, Nickolay Y ^a   Garman, Elspeth ^b   Murti, K Gopal ^c   Loncharich, Richard J ^a   Baxter, Angela J ^a   Staschke, Kirk A ^a   Laver, W Graeme ^d  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; TETRAMER;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; INFLUENZA VIRUS A; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRUS MUTANT;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0031572287     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8709     Document Type: Article

References (33)

1. Blick, T. J., Tiong, T., Sahasrabudhe, A., Varghese, J. N., Colman, P. M., Hart, G. J., Bethell, R. C., and McKimm-Breschkin, J. L. (1995). Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology 214, 475-484.
2. Bossart-Whitaker, P., Carson, M., Babu, Y. S., Smith, C. D., Laver, W. G., and Air, G. M. (1993). Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. J. Mol. Biol. 232, 1069-1083.
3. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4, 187-217.
4. Brünger, A. T. (1992). "X-PLOR, Version 3.1: A System for X-ray Crystallography and NMR" Yale Univ. Press, New Haven, CT.
5. Brünger, A. T., and Karplus, M. (1988). Polar hydrogen positions in proteins: empirical energy placement and neutron diffraction comparison. Proteins 4, 148-156.
6. Burmeister, W. P., Ruigrok, R. W., and Cusack, S. (1992). The 2.2 Å resolution crystal structure of influenza B neuraminidase and its complex to sialic acid. EMBO J. 11, 49-56.
7. Colman, P. M., and Ward, C. W. (1985). Structure and diversity of influenza virus neuraminidase. Curr. Topics Microbiol. Immunol. 11, 177-255.
8. Corfield, A. P., Wember, M., Schauer, R., and Rott, R. (1982). The specificity of viral sialidases. The use of oligosaccharide substrates to probe enzymic characteristics and strain-specific differences. Eur. J. Biochem. 124, 521-525.
9. Drzeniek, R. (1967). Differences in splitting capacity of virus and V. Cholerae neuraminidases on sialic acid type substrates. Biochem. Biopyhs. Res. Commun. 26, 631-638.
10. Els, M. C., Air, G. M., Murti, K. G., Webster, R. G., and Laver, W. G. (1985). An 18-amino acid deletion in an influenza neuraminidase. Virology 142, 241-247.
11. Gubareva, L. V., Bethell, R., Hart, G. J., Murti, K. G., Penn, C. R., and Webster, R. G. (1996). Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70, 1818-1827.
12. Hayden, F. G., Treanor, J. J., Betts, R. F., Lobo, M., Esinhart, J. D., and Hussey, E. K. (1996). Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275, 295-299.
13. Laver, W. G. (1969). Purification of influenza virus. In "Fundamental Techniques in Virology" (K. Habel and N. P. Salzman, Eds.), pp. 82-86. Academic Press, New York.
14. Laver, W. G., and Valentine, R. C. (1969). Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus. Virology 38, 105-119.
15. Laver, W. G., Colman, P. M., Webster, R. G., Hinshaw, V. S., and Air, G. M. (1984). Influenza virus neuraminidase with hemagglutinin activity. Virology 137, 314-323.
16. Luzzati, P. V. (1952). Traitement statistique des Erreurs dans la determination des structures cristallines. Acta Cryst. 5, 802-810.
17. McKimm-Breschkin, J. L., McDonald, M., Blick, T. J., and Colman, P. M. (1996). Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 225, 240-242.
18. Minor, W. (1993). "XDSPLAYF Program," Purdue University.
19. Molecular Simulations, Inc. (1994). "QUANTA," version 4.1.1, version 95.0320.
20. Molecular Simulations, Inc. (1994a). "Parameter file for CHARMM," version 22. [Copyright 1993]
21. Murphy, B. R., and Webster, R. G. (1990). Orthomyxoviruses In "Virology" (B. N. Fields, D. M. Knipe et al., Eds.), pp. 1091-1152. Raven Press, New York.
22. Myers, R. W., Lee, R. T., Lee, Y. C., Thomas, G. H., Reynolds, L. W., and Uchida, Y. (1980). The synthesis of 4-methylumbelliferyl alpha-keto-side of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase. Anal. Biochem. 101, 166-174.
23. Nagai, T., Suzuki, Y., and Yamada, H. (1995). Comparison of substrate specificities of sialidase activity between purified enzymes from influenza virus A (H1N1 and H3N2 subtypes) and B strains and their original viruses. Biol. Pharm. Bull. 18, 1251-1254.
24. Otwinowski, Z. (1993). Oscillation data reduction program. In "Proceedings of the CCP4 Study Weekend: 'Data Collection and processing.'"
25. Schauer, R. (1978). Characterization of sialic acids. Methods Enzymol. 50, 64-89.
26. Staschke, K. A., Colacino, J. M., Baxter, A. J., Air, G. M., Bansal, A., Hornback, W. J., Munroe, J. E., and Laver, W. G. (1995). Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 214, 642-646.
27. Taylor, G., Garman, E., Webster, R., Saito, T., and Laver, G. (1993). Crystallization and preliminary X-ray studies of influenza A virus neuraminidase of subtypes N5, N6, N8, N9. J. Mol. Biol. 230, 345-348.
28. Tulip, W. R., Varghese, J. N., Baker, A. T., van Donkelaar, A., Laver, W. G., Webster, R. G., and Colman, P. M. (1991). Refined atom structures of N9 subtype influenza virus neuraminidase and escape mutants. J. Mol. Biol. 221, 487-497.
29. Varghese, J. N., and Colman, P. M. (1991). Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 Å resolution. J. Mol. Biol. 221, 473-486.
30. Varghese, J. N., Laver, W. G., and Colman, P. M. (1983). Structure of influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature 303, 35-40.
31. Varghese, J. N., Epa, V. C., and Colman, P. M. (1995). Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Prot. Sci. 4, 1081-1087.
32. von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jn, B., Phan, T. V., Smythe, M. L., White, J. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hotham, V. J., Cameron, J. M., and Penn, C. R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
33. Wrigley, N. B., Skehel, J. J., Charlwood, P. A., and Brand, C. M. (1973). The size and shape of influenza virus neuraminidase. Virology 51, 525-529.